Search results for "Boron Neutron Capture Therapy"
showing 4 items of 14 documents
Dose calculation in biological samples in a mixed neutron-gamma field at the TRIGA reactor of the University of Mainz
2010
To establish Boron Neutron Capture Therapy (BNCT) for non-resectable liver metastases and for in vitro experiments at the TRIGA Mark II reactor at the University of Mainz, Germany, it is necessary to have a reliable dose monitoring system. The in vitro experiments are used to determine the relative biological effectiveness (RBE) of liver and cancer cells in our mixed neutron and gamma fi eld. We work with alanine detectors in combination with Monte Carlo simulations, where we can measure and characterize the dose. To verify our calculations we perform neutron fl ux measurements using gold foil activation and pin-diodes . Material and methods . When L- α -alanine is irradiated with ionizing …
closo-borane conjugated regulatory peptides retain high biological affinity: synthesis of closo-borane conjugated Tyr(3)-octreotate derivatives for B…
2008
Despite the improvements in cancer therapy during the past years, high-grade gliomas and many other types of cancer are still extremely resistant to current forms of therapy. Boron neutron capture therapy (BNCT) provides a promising way to destroy cancer cells without damaging healthy tissue. However, BNCT in practice is still limited due to the lack of boron-containing compounds that selectively deliver boron to cancer cells. Since many neuroendocrine tumors show an overexpression of the somatostatin receptor, it was our aim to synthesize compounds that contain a large number of boron atoms and still show high affinity toward this transmembrane receptor. The synthetic peptide Tyr (3)-octre…
Receptor-mediated uptake of boron-rich neuropeptide y analogues for boron neutron capture therapy.
2014
Peptidic ligands selectively targeting distinct G protein-coupled receptors that are highly expressed in tumor tissue represent a promising approach in drug delivery. Receptor-preferring analogues of neuropeptide Y (NPY) bind and activate the human Y1 receptor subtype (hY1 receptor), which is found in 90% of breast cancer tissue and in all breast-cancer-derived metastases. Herein, novel highly boron-loaded Y1 -receptor-preferring peptide analogues are described as smart shuttle systems for carbaboranes as (10) B-containing moieties. Various positions in the peptide were screened for their susceptibility to carbaborane modification, and the most promising positions were chosen to create a mu…
High-Resolution 3-D CZT Drift Strip Detectors for Prompt Gamma Ray and Neutron Detection in BNCT
2021
Spectroscopic imagers based on high-Z and wide-bandgap compound semiconductor detectors are widely proposed for the detection of prompt gamma rays in boron neutron capture therapy (BNCT). BNCT is a therapy based on the neutron capture reaction 10B (n,α)7Li. To perform a real-time monitoring of the spatial distribution of 10B during the treatments, the detection of the prompt gamma rays (478 keV), produced by the 7Li recoil nuclei, can be helpful. In this work, we presented the potentialities of new high-resolution CZT drift strip detectors, recently developed by our group, for BNCT measurements. The detectors, exploiting the analysis of the collected-induced charge pulses from anodes, catho…